LeMaitre Vascular, Inc.

NASDAQ:LMAT

Medical - Instruments & Supplies

Healthcare
$75.58 +1.74%

+$1.60 today

Market cap
$1.73B
Beta
0.52
P/E (TTM)
34.3
EPS (TTM)
$2.74
Dividend yield
0.96%
52W Low $79.01High $118.01

Volume 0.22M

Average 0.26M

LMAT Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

LeMaitre Vascular, Inc.NASDAQ: LMAT

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 6.0% from a year ago

Cash & equivalents stood at $26.85M at the end of Q1 FY2026, up 6.0% from a year earlier and down 4.9% from the prior quarter. Over 3 fiscal years it compounded at +13.9% a year.

Context

  • Cash & equivalents amounted to 4.3% of total assets at the end of Q1 FY2026, down 0.3 pp from a year earlier.
  • Cash & equivalents increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +6.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$26.85M-4.9% QoQ
Last fiscal yearDec 2025
$28.24M+10.3% YoY
Year agoMar 2025
$25.34M+6.0% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.0%——
1 year+10.3%——
3-year CAGR+13.9%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
28.24M USD
Year-over-year change
+10.3%
4-year CAGR
+19.5%

Cash & Equivalents vs competitors

How LMAT compares with its peers on the latest reported figures

  • LMAT's Mar 2026 cash & equivalents of $26.85M is the 7th highest of the 8 companies compared; the peer median is $205.27M.
  • Its year-over-year change of +6.0% is the 4th highest of 8, against a peer median of +0.9%.
  • Cash & equivalents amounts to 4.3% of total assets for LMAT, versus a peer median of 5.4%.
LMAT Competitors Peer median
Cash & Equivalents for LMAT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MDTMedtronic plcJul 2026$1.69B +32.8%+8.1%1.8%
BSXBoston Scientific CorporationJun 2026$539M +0.9%+30.1%1.2%
TFXTeleflex IncorporatedJun 2026$300.16M +18.3%+10.4%4.4%
PENPenumbra, Inc.Jun 2026$205.27M -51.3%+38.8%10.4%
AORTArtivion, Inc.Mar 2026$55.76M +47.9%+18.2%6.3%
ANGOAngioDynamics, Inc.Feb 2026$37.81M -15.5%+24.7%14.5%
LMATLeMaitre Vascular, Inc.Mar 2026$26.85M +6.0%+13.9%4.3%
MMSIMerit Medical Systems, Inc.Sep 2026$0 -100.0%+97.3%—
Peer median (excluding LMAT) $205.27M+0.9%+24.7%5.4%

Competitors are the stored peer set for LMAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents13.86M19.13M24.27M25.61M28.24M
Short-term Investments56.1M63.56M80.81M274.11M330.88M
Net Receivables19.63M22.04M25.06M30.06M33.61M
Inventory40.65M45.28M52.33M55.94M70.42M
Other Current Assets5.46M11.72M12.13M8.99M5.08M
Total Current Assets139.88M161.73M194.6M402.19M468.23M
Property, Plant & Equipment (Net)32.13M33.54M39.78M41.57M42.76M
Goodwill65.95M65.95M65.95M65.95M65.95M
Intangible Assets52.71M46.53M41.71M35.82M33.09M
Long-term Investments00000
Tax Assets1.57M1.75M1M1.43M759K
Other Non-current Assets568K991K3.74M4.87M4.91M
Total Non-current Assets152.92M148.74M152.18M149.63M147.46M
Total Assets292.8M310.48M346.78M551.82M615.69M
Account Payables2.34M2.9M3.73M1.76M3.65M
Short-term Debt00000
Tax Payables10.79M11.22M13.74M15.76M0
Deferred Revenue00000
Other Current Liabilities1.27M573K24K1.43M322K
Total Current Liabilities21.81M25.33M29.88M30.61M36.32M
Long-term Debt000167.77M168.65M
Deferred Tax Liabilities70K69K107K85K1.74M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.7M2.17M2.27M831K1.47M
Total Non-current Liabilities16.84M16.95M19M183.92M185.85M
Total Liabilities38.65M42.28M48.88M214.53M222.17M
Common Stock235K237K239K242K244K
Retained Earnings88.13M97.77M115.43M145.09M184.72M
Accumulated OCI(3.44M)(6.03M)(4.63M)(6.18M)(2.41M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity254.15M268.2M297.9M337.29M393.52M
Total Debt15.94M16.6M19.1M185.69M185.59M
Net Debt2.08M(2.54M)(5.17M)160.08M157.35M

LeMaitre Vascular, Inc.

NASDAQ:LMAT

Intrinsic Alpha fair value

Locked

Current Price

$75.58

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.